Immunovant, Inc.
ืœื•ื ื’

IMVT Technical Analysis ๐Ÿง™

499
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

If you understand the idea,๐ŸŽฏ press a thumb up! ๐Ÿ‘ Have a question? Don't be shy to ask! ๐Ÿค“ Interested to study how to analyze charts, follow me!

ื›ืชื‘ ื•ื™ืชื•ืจ

ื”ืžื™ื“ืข ื•ื”ืคืจืกื•ืžื™ื ืื™ื ื ืžื™ื•ืขื“ื™ื ืœื”ื™ื•ืช, ื•ืื™ื ื ืžื”ื•ื•ื™ื, ื™ื™ืขื•ืฅ ืื• ื”ืžืœืฆื” ืคื™ื ื ืกื™ืช, ื”ืฉืงืขืชื™ืช, ืžืกื—ืจื™ืช ืื• ืžื›ืœ ืกื•ื’ ืื—ืจ ื”ืžืกื•ืคืงืช ืื• ืžืื•ืฉืจืช ืขืœ ื™ื“ื™ TradingView. ืงืจื ืขื•ื“ ื‘ึพืชื ืื™ ื”ืฉื™ืžื•ืฉ.